Cancer Research Career Enhancement and Related Activities With education as the fourth pillar of its overall mission to End Cancer, The University of Texas MD Anderson Cancer Center is an accredited, degree-granting institution with numerous efforts in education, training, and career development across the spectrum of cancer research and translation, the science of cancer prevention, and clinical practice. More than 1,700 faculty and 7,000 annually appointed trainees?from high school through research postdoctoral fellows and clinical residents, as well as a community of lifelong learners among our research and administrative staff?take part in a wide array of offerings sponsored by multiple educational stakeholders from across the institution. Our long-term objective is to establish MD Anderson as a model for education and training in cancer research for a diverse, multidisciplinary research workforce through dissemination of best practices and organization of innovative, evidence-based curricula designed for 21st- century team-based science and clinical practice. Overall, the uniquely broad and rich environment for clinical and research education and professional development at MD Anderson demands easy access to high-quality resources for its learners, as individuals and as groups; for instructors to develop useful and effective activities in synergy; and for support and evaluation of such programs. With this in mind, our 5-year goals include multiple innovative efforts across all CCSG programs in 4 emphasis areas: 1) recruitment coordinated among stakeholders with new approaches that emphasize inclusiveness of underrepresented research trainees and those with disabilities; 2) facilitating access to research education via improved alignment and increased impact; 3) support applications centralized for access by all programs; and 4) program evaluation services tailored for support and improvement of current and developing efforts to improve mentorship and career development. To achieve our long-term objectives for the MD Anderson Cancer Research Career Enhancement and Related Activities (CRCE), our continuous efforts and coordinating role across the institution in education and training are described by these overall aims:
Aim 1 : To recruit, train, and promote a demographically diverse pool of research scientists who span all stages of training and faculty appointment using multiple rigorous strategies to reach broad audiences;
Aim 2 : To provide innovative and evidence-based educational and professional development opportunities in a nurturing culture of shared learning that is attuned to the needs of trainees and faculty mentors;
and Aim 3 : To serve as a coordination and support hub for innovation in education/training, sharing best practices, monitoring research training needs, and program evaluation for MD Anderson researchers, including the community of training programs at MD Anderson.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016672-43
Application #
9794670
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2019-07-01
Budget End
2020-06-30
Support Year
43
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030
Yu, Wangie; Chen, Yunyun; Dubrulle, Julien et al. (2018) Cisplatin generates oxidative stress which is accompanied by rapid shifts in central carbon metabolism. Sci Rep 8:4306
Tanco, Kimberson; Azhar, Ahsan; Rhondali, Wadih et al. (2018) The Effect of Message Content and Clinical Outcome on Patients' Perception of Physician Compassion: A Randomized Controlled Trial. Oncologist 23:375-382
Elimova, Elena; Wang, Xuemei; Qiao, Wei et al. (2018) Actionable Locoregional Relapses after Therapy of Localized Esophageal Cancer: Insights from a Large Cohort. Oncology 94:345-353
Hoadley, Katherine A; Yau, Christina; Hinoue, Toshinori et al. (2018) Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer. Cell 173:291-304.e6
Ma, Jiacheng; Huo, XiaoJiao; Jarpe, Matthew B et al. (2018) Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment. Acta Neuropathol Commun 6:103
Meisel, Jane; Zhang, Chao; Neely, Cameron et al. (2018) Evaluation of Prognosis in Hormone Receptor-Positive/HER2-Negative and Lymph Node-Negative Breast Cancer With Low Oncotype DX Recurrence Score. Clin Breast Cancer 18:347-352
Williams, Patrick; Basu, Sreyashi; Garcia-Manero, Guillermo et al. (2018) The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia. Cancer :
Koyyalagunta, Dhanalakshmi; Bruera, Eduardo; Engle, Mitchell P et al. (2018) Compliance with Opioid Therapy: Distinguishing Clinical Characteristics and Demographics Among Patients with Cancer Pain. Pain Med 19:1469-1477
Liao, Zhongxing; Lee, J Jack; Komaki, Ritsuko et al. (2018) Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer. J Clin Oncol 36:1813-1822
Ma, Junsheng; Hobbs, Brian P; Stingo, Francesco C (2018) Integrating genomic signatures for treatment selection with Bayesian predictive failure time models. Stat Methods Med Res 27:2093-2113

Showing the most recent 10 out of 12418 publications